Here are relevant reports on : antibody-drug-conjugates-market
-
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecast to 2027
The global digital pharmacy market growth is primed to transition from USD 96.5 billion in 2022 to USD 211.9 billion by 2027, showcasing a strong CAGR of 17.0%. Key drivers include the rising consumer preference for online medicine purchases, especially during and after the COVID-19 pandemic, market consolidations, and the aging population.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018
The North American interventional cardiology and peripheral vascular devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029
The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Global Forecast to 2021
The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. Emerging markets such as India, China, & Japan and growth in online marketing channels are expected to offer lucrative growth opportunities for market players in the coming years. On the other hand, factors such as regulatory issues and pricing pressures are the major factors restraining market growth.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact on Medical Tubing Market by Material (PVC, TPE & TPU, Polyolefin, and Silicone), Application (Drug Delivery, Bulk Disposable Tubing, Catheters & Cannulas, and Special Applications) and Country - Forecast to 2021
The COVID-19 Impact on Medical Tubing Market is expected to grow from USD 2.6 billion in 2020 to USD 2.9 billion by 2021, at a CAGR of 13.2% during the forecast period. Zeus Industrial Products (US), Saint Gobain Performance Plastics (France), Teleflex (US), Optinova (US), and Lubrizol Corporation (Vesta) (US), among others, are the key players operating in the medical tubing market.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Overactive Bladder Treatment Market Size by Drug type (Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) & Region - Global Forecast to 2027
The size of global overactive bladder treatment market in terms of revenue was estimated to be worth USD 3.5 billion in 2022 and is poised to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 7150
- TOC Available:
-
Nanotechnology Drug Delivery System Market by Type, End-User, Industry, Application and Region - Global Forecast to 2030
The market for drug delivery systems that use nanotechnology to improve the delivery and targeting of medicinal medicines to certain areas within the body is referred to as the nanotechnology drug delivery system market. Drug delivery techniques based on nanotechnology solve problems with conventional approaches, such as low solubility, restricted bioavailability, and lack of specificity, by utilising nanoscale materials and structures.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
ATP Assays Market by Product (Consumables (Reagents, Microplate), Instruments (Luminometer, Spectrophotometer)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, F&B, Academics) & Region - Global Forecast to 2028
The global atp assays market, valued at US$0.2 billion in 2021, stood at US$0.3 billion in 2023 and is projected to advance at a resilient CAGR of 7.8% from 2023 to 2028, culminating in a forecasted valuation of US$0.5 billion by the end of the period.The expansion of this market is primarily propelled by the shift from culture-based tests to rapid tests, rising demand for cell-based assays in research, and the rising demand for ATP assays in pharmaceutical companies.
- Published: June 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
